Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II

Cardiac hypertrophy is an important risk factor for heart failure. Epidermal growth factor receptor (EGFR) has been found to play a role in the pathogenesis of various cardiovascular diseases. The aim of this current study was to examine the role of EGFR in angiotensin II (Ang II)‐induced cardiac hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Kesong, Tian, Xinqiao, Qian, Yuanyuan, Skibba, Melissa, Zou, Chunpeng, Liu, Zhiguo, Wang, Jingying, Xu, Zheng, Li, Xiaokun, Liang, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759478/
https://www.ncbi.nlm.nih.gov/pubmed/26762600
http://dx.doi.org/10.1111/jcmm.12763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759478/
https://www.ncbi.nlm.nih.gov/pubmed/26762600
http://dx.doi.org/10.1111/jcmm.12763

Ejemplares similares